BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37094382)

  • 1. Molecular MR Imaging of Renal Fibrogenesis in Mice.
    Chen YC; Waghorn PA; Rosales IA; Arora G; Erstad DJ; Rotile NJ; Jones CM; Ferreira DS; Wei L; Martinez RVP; Schlerman FJ; Wellen J; Fuchs BC; Colvin RB; Ay I; Caravan P
    J Am Soc Nephrol; 2023 Jul; 34(7):1159-1165. PubMed ID: 37094382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
    Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
    Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
    Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
    Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
    Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
    Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.
    Widjaja AA; Shekeran SG; Adami E; Ting JGW; Tan J; Viswanathan S; Lim SY; Tan PH; Hübner N; Coffman T; Cook SA
    J Am Soc Nephrol; 2022 Apr; 33(4):718-730. PubMed ID: 35140116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
    Koepke ML; Weber M; Schulze-Lohoff E; Beirowski B; Segerer S; Gross O
    Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of renal fibrosis.
    Zeisberg M; Soubasakos MA; Kalluri R
    Methods Mol Med; 2005; 117():261-72. PubMed ID: 16118458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse.
    Hahm K; Lukashev ME; Luo Y; Yang WJ; Dolinski BM; Weinreb PH; Simon KJ; Chun Wang L; Leone DR; Lobb RR; McCrann DJ; Allaire NE; Horan GS; Fogo A; Kalluri R; Shield CF; Sheppard D; Gardner HA; Violette SM
    Am J Pathol; 2007 Jan; 170(1):110-25. PubMed ID: 17200187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.
    Gross O; Girgert R; Beirowski B; Kretzler M; Kang HG; Kruegel J; Miosge N; Busse AC; Segerer S; Vogel WF; Müller GA; Weber M
    Matrix Biol; 2010 Jun; 29(5):346-56. PubMed ID: 20307660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis.
    Zhou IY; Clavijo Jordan V; Rotile NJ; Akam E; Krishnan S; Arora G; Krishnan H; Slattery H; Warner N; Mercaldo N; Farrar CT; Wellen J; Martinez R; Schlerman F; Tanabe KK; Fuchs BC; Caravan P
    Radiology; 2020 Jul; 296(1):67-75. PubMed ID: 32343209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome.
    Andrews KL; Betsuyaku T; Rogers S; Shipley JM; Senior RM; Miner JH
    Am J Pathol; 2000 Jul; 157(1):303-11. PubMed ID: 10880400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.
    Heidet L; Borza DB; Jouin M; Sich M; Mattei MG; Sado Y; Hudson BG; Hastie N; Antignac C; Gubler MC
    Am J Pathol; 2003 Oct; 163(4):1633-44. PubMed ID: 14507670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finerenone Added to RAS/SGLT2 Blockade for CKD in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3-/- Mice.
    Zhu Z; Rosenkranz KAT; Kusunoki Y; Li C; Klaus M; Gross O; Angelotti ML; Antonelli G; Cirillo L; Romagnani P; Bouteldja N; Sadr AV; Bülow RD; Boor P; Anders HJ
    J Am Soc Nephrol; 2023 Sep; 34(9):1513-1520. PubMed ID: 37428955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell-specific collagen type IV-α
    Funk SD; Bayer RH; Miner JH
    Am J Physiol Renal Physiol; 2019 May; 316(5):F830-F837. PubMed ID: 30724107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
    Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
    J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGF-D Is Dispensable for the Development and Progression of Murine Alport Syndrome.
    Firat EAM; Buhl EM; Bouteldja N; Smeets B; Eriksson U; Boor P; Klinkhammer BM
    Am J Pathol; 2024 May; 194(5):641-655. PubMed ID: 38309427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel model of autosomal dominant Alport syndrome in Dalmatian dogs.
    Hood JC; Huxtable C; Naito I; Smith C; Sinclair R; Savige J
    Nephrol Dial Transplant; 2002 Dec; 17(12):2094-8. PubMed ID: 12454218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome.
    Cosgrove D; Meehan DT; Grunkemeyer JA; Kornak JM; Sayers R; Hunter WJ; Samuelson GC
    Genes Dev; 1996 Dec; 10(23):2981-92. PubMed ID: 8956999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model.
    Sannomiya Y; Kaseda S; Kamura M; Yamamoto H; Yamada H; Inamoto M; Kuwazuru J; Niino S; Shuto T; Suico MA; Kai H
    Ren Fail; 2021 Dec; 43(1):510-519. PubMed ID: 33706638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models.
    Rubel D; Boulanger J; Craciun F; Xu EY; Zhang Y; Phillips L; Callahan M; Weber W; Song W; Ngai N; Bukanov NO; Shi X; Hariri A; Husson H; Ibraghimov-Beskrovnaya O; Liu S; Gross O
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.